Published in Women's Health Weekly, September 21st, 1998
Ettinger et al. reported their findings to the European Congress on Osteoporosis, held September 11-15, 1998, in Berlin, Germany.
The trial is continuing to assess the effect of treatment after 36 months, but the MORE study, a double-blind, placebo-controlled trial involving 180 centers worldwide with more than 7,700 osteoporotic women...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly